Revance Therapeutics shares owned by Assenagon Asset Management
Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Assenagon Asset Management
from 13F filings
Historical chart of Assenagon Asset Management investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by Assenagon Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Revance Therapeutics by Assenagon Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $978k | 199k | 4.92 |
| 2023-12-31 | $1.7M | 199k | 8.79 |
| 2023-09-30 | $4.7M | 414k | 11.47 |
| 2023-03-31 | $6.3M | 195k | 32.21 |
| 2022-12-31 | $3.6M | 192k | 18.46 |
| 2022-09-30 | $16M | 576k | 27.00 |
| 2022-06-30 | $1.8M | 131k | 13.82 |
| 2022-03-31 | $2.4M | 122k | 19.50 |
| 2021-12-31 | $1.9M | 119k | 16.32 |
| 2021-06-30 | $4.2M | 142k | 29.64 |
| 2020-03-31 | $242k | 16k | 14.78 |
More positions owned by Assenagon Asset Management
View all positions for Assenagon Asset Management